{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:10:18Z","timestamp":1793067018134,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010813","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T00:00:00Z","timestamp":1393804800000}}],"reference-count":154,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010813.pub2","type":"journal-article","created":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T16:09:03Z","timestamp":1393862943000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":144,"title":["Combined oral contraceptives: venous thrombosis"],"prefix":"10.1002","volume":"2014","author":[{"given":"Marcos","family":"de Bastos","sequence":"first","affiliation":[{"name":"Instituto Previdencia dos Servidores do Estado de Minas Gerais; Minas Gerais Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardine H.","family":"Stegeman","sequence":"additional","affiliation":[{"name":"University College London; Department of Epidemiology and Public Health; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits R.","family":"Rosendaal","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center; Epidemiology; PO Box 9600 Leiden Netherlands 2300RC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Van Hylckama Vlieg","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center; Department of Clinical Epidemiology; PO Box 9600 Leiden Netherlands 2300RC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans M","family":"Helmerhorst","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center; Department of Gynaecology, Division of Reproductive Medicine and Dept. of Clinical Epidemiology; PO Box 9600 Albinusdreef 2 Leiden Netherlands NL 2300 RC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Stijnen","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center; Department of Medical Statistics; PO Box 9600 Leiden Netherlands 2300 RC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf M","family":"Dekkers","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center; Department of Clinical Epidemiology; PO Box 9600 Leiden Netherlands 2300RC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,3,3]]},"reference":[{"key":"10.1002\/14651858.CD010813.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-0037-1614213","article-title":"Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism","volume":"79","author":"Andersen","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/jth.12224","article-title":"Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?","volume":"11","author":"Bird","year":"2013","journal-title":"J Thromb Haemost."},{"key":"10.1002\/14651858.CD010813.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archinte.159.1.65","article-title":"Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias","volume":"159","author":"Bloemenkamp","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0005|cit5","first-page":"259","article-title":"Safety of modern oral contraceptives","volume":"347","author":"Farmer","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0010-7824(98)00002-X","article-title":"The risks of venous thromboembolic disease among German women using oral contraceptives: a database study","volume":"57","author":"Farmer","year":"1998","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2125.2000.00198.x","article-title":"A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives","volume":"49","author":"Farmer","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"E1319","DOI":"10.1503\/cmaj.110463","article-title":"Gronich N, Lavi I, Rennert G","volume":"183","author":"Gronich","year":"2011","journal-title":"CMAJ"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.0001-6349.2004.0533.x","article-title":"Pulmonary embolism associated with combined oral contraceptives: reporting incidences and potential risk factors for a fatal outcome","volume":"83","author":"Hedenmalm","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0010-7824(01)00309-2","article-title":"A methodological study on venous thromboembolism and steroid hormone use","volume":"65","author":"Heinemann","year":"2002","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.contraception.2009.12.014","article-title":"Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation 'pill scare'","volume":"81","author":"Heinemann","year":"2010","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(99)01257-X","article-title":"Venous thromboembolism among new users of different oral contraceptives","volume":"354","author":"Herings","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.contraception.2006.02.002","article-title":"Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"d2151","DOI":"10.1136\/bmj.d2151","article-title":"Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data","volume":"342","author":"Jick","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0010-7824(96)00112-6","article-title":"The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"54","author":"Lewis","year":"1996","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.ATV.19.3.700","article-title":"Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis","volume":"19","author":"Martinelli","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(00)02382-5","article-title":"Oral contraceptives and fatal pulmonary embolism","volume":"355","author":"Parkin","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"d2139","DOI":"10.1136\/bmj.d2139","article-title":"Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database","volume":"342","author":"Parkin","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.0001-6349.2004.00574.x","article-title":"Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users","volume":"83","author":"Samuelsson","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/humrep\/14.6.1500","article-title":"Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database","volume":"14","author":"Todd","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study","volume":"346","author":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contarception","year":"1995","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0025|cit25","first-page":"1582","article-title":"Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","author":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0026|cit26","first-page":"326","article-title":"Tidsskr","volume":"120","author":"Amundsen","year":"2000","journal-title":"Nor Laegeforen"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"620. e1-620.e3","DOI":"10.1016\/j.ajog.2009.01.038","article-title":"Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women","volume":"200","author":"Austin","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0028|cit28","first-page":"373-8","article-title":"A population-based case-control study","volume":"126","author":"Barsoum","year":"2010","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0029|cit29","first-page":"1399","article-title":"Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours","volume":"7817","author":"Boston Collaborative Drug Surveillance Programme","year":"1973","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.thromres.2012.05.024","article-title":"Risk factors for venous thromboembolism in pre- and postmenopausal women","volume":"130","author":"Bergendal","year":"2012","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0031|cit31","first-page":"667","article-title":"Pulmonary Embolism in Adolescents","volume":"140","author":"Bernstein","year":"1986","journal-title":"AJDC"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0032|cit32","first-page":"465","article-title":"Case control studies of the risk factors for deep-vein thrombosis in an adult population hospitalized in internal medicine","volume":"45","author":"Bonifacj","year":"1997","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(80)91550-0","article-title":"Oral contraceptives and Thromboembolic disease: effects of lowering oestrogen contente","volume":"8178","author":"Bottiger","year":"1980","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0034|cit34","first-page":"19","article-title":"Int J Fertil","volume":"44","author":"Burnhill","year":"1999","journal-title":"Womens Med"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0035|cit35","first-page":"22-26","article-title":"Oral contraceptives steroids and thrombophlebitis","volume":"71","author":"Diddle","year":"1978","journal-title":"J Tenn Med Assoc"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1783\/147118910791749416","article-title":"Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study","volume":"36","author":"Dinger","year":"2010","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"297-305","DOI":"10.1002\/pds.1554","article-title":"Supplementary data collection with case-cohort analysis to address potential confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores","volume":"17","author":"Eng","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(96)07496-X","article-title":"Population-based study of risk of venous thromboembolism associated with various oral contraceptives","volume":"349","author":"Farmer","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0040|cit40","first-page":"259","article-title":"Thrombophlebitis among oral contraceptives for contraception","volume":"38","author":"Fuertes","year":"1971","journal-title":"Obstet Gynecol"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115799","article-title":"Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease","volume":"133","author":"Gerstman","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/107602960401000308","article-title":"Effect of Age on Oral Contraceptive-Induced Venous Thrombosis","volume":"10","author":"Girolami","year":"2004","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(96)07308-4","article-title":"Prospective study of exogenous hormones and risk of pulmonary embolism in women","volume":"348","author":"Grodstein","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"440","DOI":"10.5694\/j.1326-5377.1974.tb70899.x","article-title":"Anovulants: thrombosis and other associated changes","volume":"2","author":"Grounds","year":"1974","journal-title":"Med J Aust"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.contraception.2012.05.105","article-title":"Types of Combined Oral Contraceptives Used by Us Women, Including Women at Risk of Venous Thromboembolism","volume":"86","author":"Hall","year":"2012","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2165\/00002018-200528100-00007","article-title":"Fatal venous thromboembolism associated with different combined oral contraceptives. A study of incidences and potential biases in spontaneous reporting","volume":"28","author":"Hedenmalm","year":"2005","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0047|cit47","first-page":"183","article-title":"Venous thromboembolism and oral contraceptive use: a methodological study of diagnostic suspicion and referral bias","volume":"5","author":"Heinemann","year":"Reprod Health Care 2000","journal-title":"Eur J Contracept"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0048|cit48","first-page":"91","article-title":"Venous thromboembolism in relation to oral contraceptive use","volume":"69","author":"Helmrich","year":"1987","journal-title":"Obstet Gynecol"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0049|cit49","first-page":"127-8","article-title":"Venous thromboembolism and oral contraceptives","volume":"354","author":"Herings","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0050|cit50","first-page":"U1176","article-title":"\u00a0Specific oral contraceptive use and venous thromboembolism resulting in hospital admission","volume":"117","author":"Heuser","year":"2004","journal-title":"N Z M J"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0002-9378(90)90568-R","article-title":"Cardiovascular death among women under 40 years of age using low-estrogen oral contraceptives and intrauterine devices in Finland from 1975 to 1984","volume":"163","author":"Hirvonen","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archinte.167.9.935","article-title":"Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom","volume":"167","author":"Huerta","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"193-9","DOI":"10.1136\/bmj.2.5599.193","article-title":"Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age","volume":"2","author":"Inman","year":"1968","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bmj.2.5703.203","article-title":"Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs","volume":"2","author":"Inman","year":"1970","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0055|cit55","first-page":"2","article-title":"IPPF","volume":"10","author":"Anonymous","year":"1976","journal-title":"Med Bull"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0056|cit56","first-page":"3050","article-title":"Thromboembolism and combined oral contraceptives. Spontaneous reporting of adverse drug reactions indicate at least similar risk with themost recent contraceptives","volume":"100","author":"Kieler","year":"2003","journal-title":"L\u00e4kartidningen"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0057|cit57","first-page":"90","article-title":"[Hormonal contraceptive agents as a risk factor in the development of acute thromboembolic diseases]","volume":"12","author":"Lambrekht","year":"1986","journal-title":"Khirurgiia (Mosk)"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"21S-28S","DOI":"10.1016\/S0010-7824(00)00147-5","article-title":"Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference?","volume":"62","author":"Lawrenson","year":"2000","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1053\/euhj.2001.3082","article-title":"Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use","volume":"23","author":"Legnani","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0060|cit60","first-page":"189","article-title":"The role of bias in observational studies","volume":"55","author":"Lewis","year":"1997","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/humrep\/14.6.1493","article-title":"The differential risk of oral contraceptives: the impact of full exposure history","volume":"14","author":"Lewis","year":"1999","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0140-6736(05)77607-8","article-title":"Venous thromboembolism and oral contraceptives","volume":"354","author":"Lewis","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0010-7824(98)00033-X","article-title":"Oral contraceptives and venous thromboembolism. A case-control study","volume":"57","author":"Lidegaard","year":"1998","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"S62-S67","DOI":"10.1053\/ob.1998.v179.a91674","article-title":"Thrombotic diseases in young women and the influence of oral contraceptives","volume":"179","author":"Lidegaard","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0065|cit65","first-page":"4549","article-title":"Oral contraceptives and thrombosis","volume":"163 (34)","author":"Lidegaard","year":"2001","journal-title":"Ugeskr Laeger"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"234-240","DOI":"10.1111\/j.1365-2141.2008.07460.x","article-title":"The relationship between lifestyle factors and venous thromboembolism among women: a report from the MISS study","volume":"144","author":"Lindqvist","year":"2009","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/pds.2630020107","article-title":"A concurrent cohort study of oral contraceptive use and cardiovascular risks","volume":"2","author":"Lis","year":"1993","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0069|cit69","first-page":"81-102","article-title":"Ovulationshemmer und Venenerkrankungen","volume":"4","author":"Ludwig","year":"1970","journal-title":"Ergebnisse der Angiologie und Phlebologie"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00008571-200310000-00002","article-title":"Pharmacogenetic aspects of the use of oral contraceptives and the risk of thrombosis","volume":"13","author":"Martinelli","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/bmj.280.6224.1157","article-title":"Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-mcg oestrogen preparations","volume":"280","author":"Meade","year":"1980","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0072|cit72","first-page":"1507","article-title":"Hormonal contraceptives and cardiovascular risk. Results of an East German multicenter case control study]","volume":"110","author":"Meinel","year":"1988","journal-title":"Zentralbl Gynakol"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0073|cit73","first-page":"108","article-title":"What is the risk of venous thromboembolism (VT) among women taking third generation oral contraceptives ((COCs) in comparison with those taking contraceptives containing levonorgestrel?","volume":"50","author":"Meurer","year":"2001","journal-title":"The Journal of Family Practice"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13625180008500402","article-title":"The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives","volume":"5","author":"Nightingale","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0075|cit75","first-page":"2348","article-title":"[Venous thromboembolic disease and oral contraceptives]","volume":"148","author":"Overgaard","year":"1986","journal-title":"Ugeskr Laeger"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"98-102","DOI":"10.1111\/j.1365-2125.2005.02373.x","article-title":"Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin","volume":"60","author":"Pearce","year":"2005","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jama.1979.03300110022020","article-title":"Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors","volume":"242","author":"Petitti","year":"1979","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0078|cit78","first-page":"331","article-title":"Risk of venous thromboembolism and stroke associated with oral contraceptives. Role of congenital thrombophilias","volume":"87","author":"Pini","year":"1996","journal-title":"Recenti Prog Med"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0079|cit79","first-page":"299","article-title":"Oral contraceptives and nonfatal vascular disease - recent experience","volume":"59","author":"Porter","year":"1982","journal-title":"Obstet Gynecol"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0080|cit80","first-page":"1","article-title":"Oral contraceptives and nonfatal vascular disease","volume":"66","author":"Porter","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0081|cit81","first-page":"547","article-title":"Safety of combined oral contraceptive pills (letter)","volume":"347","author":"Poulter","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.20591","article-title":"Risk factors for thrombophilia in extrahepatic portal vein obstruction","volume":"41","author":"Primignani","year":"2005","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.1992.03490130077034","article-title":"A Prospective investigation of pulmonary embolism in women and men","volume":"268","author":"Quinn","year":"1992","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0084|cit84","first-page":"393","article-title":"Oral contraceptives, venous thrombosis, and varicose veins","volume":"28","author":"Royal College of General Practitioners' oral contraception study","year":"1978","journal-title":"Journal ofthe Royal College of General Practitioners"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0085|cit85","first-page":"315","article-title":"Oral contraceptives and venous thromboembolism: a case-control study designed to minimize detection bias","volume":"10","author":"Realini","year":"1997","journal-title":"J Am Board Fam Pract"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0086|cit86","first-page":"169","article-title":"VTE risk in users of combined oral contraceptives: Impact of a 24-day regimen containing drospirenone","volume":"Conference","author":"Reed","year":"2012","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/jth.12060","article-title":"The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy","volume":"11","author":"Roach","year":"2013","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"427-436","DOI":"10.1002\/pds.896","article-title":"Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette1): observational studies using the UK General Practice Research Database","volume":"13","author":"Seaman","year":"2004","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.AOG.0000279448.62221.a8","article-title":"Risk of thromboembolism in women taking ethinylestradiol\/drospirenone and other oral contraceptives","volume":"110(3)","author":"Seeger","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1002\/14651858.CD010813.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/oxfordjournals.aje.a121045","article-title":"Oral contraceptives and relative risk of death from venous and pulmonary thromboembolism in the United States","volume":"90","author":"Seigel","year":"1969","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"3-10","DOI":"10.1016\/j.contraception.2004.02.010","article-title":"Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives","volume":"70","author":"Sidney","year":"2004","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/pds.2630020105","article-title":"Trinational case control study of OCs and health","volume":"2","author":"Spitzer","year":"1993","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.aje.a112148","article-title":"Thrombosis with low-estrogen oral contraceptives","volume":"102","author":"Stolley","year":"1975","journal-title":"Am J Epidemiol"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0010-7824(97)00119-4","article-title":"First-time use of newer oral contraceptives and the risk of venous thromboembolism","volume":"56","author":"Suissa","year":"1997","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD010813.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ije\/21.1.48","article-title":"Risk factors for fatal venousthromboembolism in young women: A case-control study","volume":".21","author":"Thorogood","year":"1992","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1046\/j.1538-7836.2003.00313.x","article-title":"Prevalence and risk factors of venoud non-fatal venous thromboembolism in the active population of the VITA project","volume":"1","author":"Tosetto","year":"2003","journal-title":"J Thromb Haermost"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2478\/V10133-010-0054-Y","article-title":"Impact of oral contraceptives and smoking on arterial and deep venous thrombosis: A retrospective case-control study","volume":"24","author":"Tzankova","year":"2010","journal-title":"Biotechnology & Biotechnological Equipment"},{"issue":"5","key":"10.1002\/14651858.CD010813.pub2-BIB0098|cit98","first-page":"8","article-title":"Ginekol","volume":"49","author":"Tsankova","journal-title":"2010"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF01318609","article-title":"Hospitalization of young women after selected cardiovascular and thromboembolic incidents in Austria 1993 and 1994","volume":"42","author":"Ulmer","year":"1997","journal-title":"Soz-Praventivmed"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0100|cit100","first-page":"535","article-title":"[Risk of venous thromboembolism among users of third-generation oral contraceptives]","volume":"30","author":"Vallee","journal-title":"Presse Med"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1055\/s-0038-1657602","article-title":"The Leiden Thrombophilia Study (LETS)","volume":"78","author":"Meer","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"issue":"5658","key":"10.1002\/14651858.CD010813.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.2.5658.651","article-title":"Investigation of relation between use of oral contraceptives andthromboembolic disease. A further report","volume":"2","author":"Vessey","year":"1969","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/bmj.292.6519.526","article-title":"Oral contraceptives and venous thromboembolism: findings in a large prospective study","volume":"292","author":"Vessey","year":"1986","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0104|cit104","first-page":"417","article-title":"Cardiovascular disease and use of oral contraceptives","volume":"67","author":"WHO Collaborative Study","year":"1989","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0105|cit105","first-page":"1502","article-title":"Risk factors of venous thromboembolism (VT) in Thai reproductive aged female: King Chulalongkorn Memorial Hospital experience","volume":"88","author":"Worralurt","year":"2005","journal-title":"J Med Assoc Thai"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1726-4901(09)70339-9","article-title":"Cardiovascular diseases and the risk of venous thromboembolism: A hospital-based case-control study","volume":"70","author":"Yang","year":"2007","journal-title":"J Chin Med Assoc"},{"issue":"3","key":"10.1002\/14651858.CD010813.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1521-6934(03)00015-4","article-title":"Thrombophilias and gynaecology","volume":"17","author":"Bloemenkamp","year":"2003","journal-title":"Best Practice & Research. Clinical Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1538-7836.2009.03711.x","article-title":"APC resistance: biological basis and acquired influences","volume":"8","author":"Castoldi","year":"2010","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"27","key":"10.1002\/14651858.CD010813.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7270","article-title":"Evaluating non-randomised intervention studies","volume":"7","author":"Deeks","year":"2003","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD010813.pub2-BIB0111|cit111","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003989.pub5","article-title":"20 \u00b5g versus >20 \u00b5g estrogen combined oral contraceptives for contraception","author":"Gallo","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"e1001026","DOI":"10.1371\/journal.pmed.1001026","article-title":"Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview","volume":"8","author":"Golder","year":"2011","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/archinte.164.18.1965","article-title":"Risk of venous thromboembolic disease associated with hormonal contraceptives and hormonal replacement therapy: a clinical review","volume":"164","author":"Gomes","year":"2004","journal-title":"Archives of Internal Medicine"},{"issue":"15","key":"10.1002\/14651858.CD010813.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10150","article-title":"Measurement of the clinical and cost-effectiveness of non-invasive diagnostic testing strategies for deep vein thrombosis","volume":"10","author":"Goodacre","year":"2006","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"328-36","DOI":"10.1016\/j.contraception.2006.12.018","article-title":"Range of published estimates of venous thromboembolism incidence in young women","volume":"75","author":"Heinemann","year":"2007","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0116|cit116","first-page":"101","article-title":"Pharmacology of progestins: 17 alpha-hydroxyprogesterone derivatives and progestins of the first and second generation","volume-title":"Progestins and antiprogestins in clinical practice","author":"Henzl","year":"2000"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0117|cit117","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1524-4733.2008.00347.x","article-title":"Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons","volume":"11","author":"Jansen","year":"2008","journal-title":"Value in Health"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(61)91061-3","article-title":"Pulmonary embolism","volume":"278","author":"Jordan","year":"1961","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"I22","DOI":"10.1161\/01.CIR.0000078464.82671.78","article-title":"Natural history of venous thromboembolism","volume":"107","author":"Kearon","year":"2003","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00001721-200207000-00001","article-title":"Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation","volume":"13","author":"Kemmeren","year":"2002","journal-title":"Blood Coagulation & Fibrinolysis"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-0037-1612973","article-title":"Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation","volume":"87","author":"Kemmeren","year":"2002","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood-2003-04-1285","article-title":"Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor V Leiden mutation: a randomized trial","volume":"103","author":"Kemmeren","year":"2004","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.contraception.2007.10.004","article-title":"Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables","volume":"77","author":"Kluft","year":"2008","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10654-005-7919-7","article-title":"Methods to account for attrition in longitudinal data: do they work?","volume":"20","author":"Kristman","year":"2005","journal-title":"European Journal of Epidemiology"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2165\/00003495-199856050-00008","article-title":"Dienogest","volume":"56","author":"Kuhl","year":"1998","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0128|cit128","first-page":"191","article-title":"Oral contraceptives and venousthromboembolism: a systematic review and meta-analysis.","volume":"35","author":"Manzoli","year":"2012","journal-title":"Drug Saf"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"692-9","DOI":"10.1111\/j.1538-7836.2007.02450.x","article-title":"Incidence and mortality of venous thrombosis: a population-based study","volume":"5","author":"Naess","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1370\/afm.667","article-title":"The Joint American Academy of Family Physicians\/American College of Physicians Panel on deep venous thrombosis\/pulmonary embolism. Practice guideline from the American Academy of Family Physicians and the American College of Physicians","volume":"5","author":"Qaseem","year":"2007","journal-title":"Annals of Family Medicine"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajog.2005.12.007","article-title":"Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinylestradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables","volume":"195","author":"Rad","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/ije\/dym018","article-title":"Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography","volume":"36","author":"Sanderson","year":"2007","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Human Reproduction Updates"},{"issue":"1-2","key":"10.1002\/14651858.CD010813.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"151-7","DOI":"10.1016\/j.maturitas.2008.11.011","article-title":"Pharmacological profile of progestins","volume":"61","author":"Sitruk-Ware","year":"2008","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0135|cit135","unstructured":"StataCorp LP STATA Data analysis and statistical software 2011"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2141.2003.04443.x","article-title":"Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women","volume":"122","author":"Tans","year":"2003","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/eurheartj\/ehn106","article-title":"Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke","volume":"29","author":"Thijs","year":"2008","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/oxfordjournals.bmb.a072592","article-title":"Combined oral contraceptives: risks and benefits","volume":"49","author":"Thorogood","year":"1993","journal-title":"British Medical Bulletin"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1111\/j.1538-7836.2010.04065.x","article-title":"Predictors of the\u00a0post-thrombotic syndrome\u00a0with non-invasive venous examinations in patients 6 weeks after a first episode of deep vein thrombosis","volume":"8","author":"Tick","year":"2010","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venousthrombosis associated with injectable depot-medroxyprogesterone acetate contraceptivesor a levonorgestrel intrauterine device","volume":"30","author":"Hylckama","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0141|cit141","first-page":"257-66","article-title":"Hormone therapies and venous thromboembolism: where are we now?","volume":"9","author":"Hylckama Vlieg","year":"2011","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0002-9378(97)70289-8","article-title":"Third-generation oral contraceptive and deep venous thrombosis: from epidemiologic controversy to new insight in coagulation","volume":"177","author":"Vandenbroucke","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/bmj.329.7456.2","article-title":"Benefits and harms of drug treatments","volume":"329","author":"Vandenbroucke","year":"2004","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1503\/cmaj.051484","article-title":"What is the best evidence for determining harms of medical treatment?","volume":"174","author":"Vandenbroucke","year":"2006","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1371\/journal.pmed.0050067","article-title":"Observational research, randomised trials, and two views of medical science","volume":"5","author":"Vandenbroucke","year":"2008","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0140-6736(95)92535-X","article-title":"Accuracy of clinical assessment of deep-vein thrombosis","volume":"345","author":"Wells","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0149|cit149","first-page":"1","article-title":"Lower dose pills","volume":"16","author":"Wharton","year":"1988","journal-title":"Population Reports"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"I4","DOI":"10.1161\/01.CIR.0000078468.11849.66","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White","year":"2003","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jrsm.1045","article-title":"Consistency and inconsistency in networkmeta-analysis: model estimation using multivariate meta-regression","volume":"3","author":"White","year":"2012","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","author":"Anonymous","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0153|cit153","first-page":"1-89","article-title":"Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group","volume":"877","author":"Anonymous","year":"1998","journal-title":"World Health Organization Technical Report Series"},{"key":"10.1002\/14651858.CD010813.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman\u00a0BH","year":"2013","journal-title":"BMJ"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010813.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T14:32:54Z","timestamp":1699626774000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010813.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Fertility Regulation Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,3]]},"references-count":154,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010813.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,3]]}}}